The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-Alcoholic Steatohepatitis (NASH)

被引：0
|
作者：
Drescher, Hannah [1 ]
Weiskirchen, Ralf [2 ]
Tolba, Rene [3 ,4 ]
Trautwein, Christian [1 ]
Kroy, Daniela [1 ]
机构：
[1] Rhein Westfal TH Aachen, Univ Hosp, Dept Internal Med 3, Aachen, Germany
[2] Rhein Westfal TH Aachen, Univ Hosp, Inst Mol Pathobiochem Expt Gene Therapy & Clin Ch, Cleveland, OH USA
[3] Rhein Westfal TH Aachen, Univ Hosp, Inst Lab Anim Sci & Expt Surg, Cleveland, OH USA
[4] Rhein Westfal TH Aachen, Univ Hosp, Cent Lab Lab Anim Sci, Cleveland, OH USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1816
引用
收藏
页码：1031A / 1031A
页数：1
相关论文
共 50 条
  • [21] Progression of disease in non-alcoholic steatohepatitis (NASH)
    Kaplan, KJ
    Katz, DE
    Holtzmuller, KC
    Sjogren, MH
    Goodman, ZD
    LABORATORY INVESTIGATION, 1999, 79 (01) : 164A - 164A
  • [22] Laboratory predictors of non-alcoholic steatohepatitis (NASH)
    Bilici, A
    Unsal, B
    McGee, A
    Bolukoglu, H
    Ankoma-Sey, V
    Edwards, M
    HEPATOLOGY, 1999, 30 (04) : 438A - 438A
  • [23] THYROID HORMONE DECREASES HEPATIC STEATOSIS, INFLAMMATION, AND FIBROSIS IN A DIETARY MOUSE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)
    Zhou, Jin
    HEPATOLOGY, 2020, 72 : 1040 - 1040
  • [24] NON-ALCOHOLIC STEATOHEPATITIS (NASH): 2 COMPLEMENTARY DIETARY MOUSE MODELS
    Machado, M. V.
    Michelotti, G. A.
    Xie, G.
    Boursier, J.
    de Almeida, T. Pereira
    Kruger, L.
    Karaca, G.
    Guy, C.
    Diehl, A. M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S695 - S695
  • [25] Rosiglitazone improves characteristics of Non-Alcoholic Steatohepatitis (NASH) in a mouse model of metabolic syndrome
    Gupte, Anisha A.
    Liu, Joey Z.
    Minze, Laurie J.
    Ren, Yuelan
    Wiles, Jessica R.
    Collins, Alan R.
    Lyon, Christopher J.
    Hsueh, Willa A.
    FASEB JOURNAL, 2010, 24
  • [26] Oyster extracts attenuate pathological changes in non-alcoholic steatohepatitis (NASH) mouse model
    Watanabe, Mitsugu
    Fuda, Hirotoshi
    Okabe, Hiroaki
    Joko, Sae
    Miura, Yusuke
    Hui, Shu-Ping
    Yimin
    Hamaoka, Naohiro
    Miki, Emiko
    Chiba, Hitoshi
    JOURNAL OF FUNCTIONAL FOODS, 2016, 20 : 516 - 531
  • [27] TAUROURSODEOXYCHOLIC ACID ATTENUATES HEPATIC FIBROSIS IN A MOUSE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS
    Cho, E. J.
    Yu, S. J.
    Lee, J. -H.
    Yoon, J. -H.
    Lee, H. -S.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S485 - S485
  • [28] Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Miele, Luca
    Forgione, Alessandra
    Gasbarrini, Giovanni
    Grieco, Antonio
    TRANSLATIONAL RESEARCH, 2007, 149 (03) : 114 - 125
  • [29] A Novel Mouse Model of Accelerated Non-Alcoholic Steatohepatitis
    Malhotra, P.
    Han, E.
    Ooka, K.
    Muthusamy, S.
    Gill, R.
    Dudeja, P.
    Aloman, C.
    Alrefai, W.
    FASEB JOURNAL, 2015, 29
  • [30] Chemerin in a Mouse Model of Non-alcoholic Steatohepatitis and Hepatocarcinogenesis
    Haberl, Elisabeth M.
    Pohl, Rebekka
    Rein-Fischboeck, Lisa
    Feder, Susanne
    Sinal, Christopher J.
    Buechler, Christa
    ANTICANCER RESEARCH, 2018, 38 (05) : 2649 - 2657
12345